# Kiora Pharmaceuticals (KPRX) — Earnings

KPRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/kprx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | $0.01 |
| EPS estimate | −$0.74 |
| EPS surprise | +101.36% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $750,000.00 |
| Reported | Nov 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1372514/000137251425000078/kprx-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 7, 2025 | −$0.74 | $0.01 | 101.36% | $750,000.00 | — |
| Q2 2025 | Aug 8, 2025 | −$0.61 | −$0.54 | 10.74% | $750,000.00 | $750,000.00 |
| Q1 2025 | May 9, 2025 | −$0.67 | −$0.52 | 22.39% | $750,000.00 | — |
| Q4 2024 | Mar 25, 2025 | −$0.55 | −$1.21 | -120.00% | $750,000.00 | — |
| Q3 2024 | Nov 8, 2024 | −$0.76 | −$0.81 | -6.12% | $10,500.00 | — |
| Q2 2024 | Aug 9, 2024 | −$0.86 | −$0.53 | 38.13% | — | $20,000.00 |
| Q1 2024 | May 10, 2024 | $2.48 | $3.42 | 38.18% | $16.0M | $16.0M |
| Q4 2023 | Mar 25, 2024 | −$3.51 | −$2.61 | 25.64% | — | — |
| Q3 2023 | Nov 9, 2023 | −$4.68 | −$8.01 | -71.15% | — | — |
| Q2 2023 | Aug 8, 2023 | −$9.59 | −$7.11 | 25.82% | — | — |
| Q3 2022 | Nov 9, 2022 | −$34.52 | −$54.27 | -57.24% | — | — |
| Q2 2022 | Aug 12, 2022 | −$81.00 | −$64.80 | 20.00% | — | — |
| Q1 2022 | Jul 8, 2022 | −$82.80 | −$97.20 | -17.39% | — | — |
| Q4 2021 | Apr 15, 2022 | −$95.40 | −$237.60 | -149.06% | — | — |
| Q3 2021 | Nov 15, 2021 | −$121.20 | −$104.40 | 13.86% | — | — |
| Q2 2021 | Aug 12, 2021 | −$150.00 | −$126.00 | 16.00% | — | — |
| Q1 2021 | May 12, 2021 | −$138.60 | −$133.20 | 3.90% | — | — |
| Q4 2020 | Mar 25, 2021 | −$158.40 | −$183.60 | -15.91% | — | — |
| Q3 2020 | Nov 9, 2020 | −$151.20 | −$158.40 | -4.76% | — | — |
| Q1 2020 | May 6, 2020 | $0.00 | −$154.80 | 0.00% | — | — |

## Frequently Asked Questions

### When did Kiora Pharmaceuticals (KPRX) last report earnings?

Kiora Pharmaceuticals last reported on Nov 7, 2025, covering fiscal Q3 2025.

### Did KPRX beat earnings estimates?

Yes. Kiora Pharmaceuticals reported EPS of $0.01 for Q3 2025 against a −$0.74 estimate — a 101.36% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).